Ex-OpenAI Science Head Kevin Weil Launches Startup With $215 Million

Covered by 3 sourcesPublished 22 hours ago

Kevin Weil, ex-head of AI science at OpenAI, has founded a new startup focused on accelerating drug development using artificial intelligence, backed by $215 million in funding.

Covered by 3 sources

Unite.AI
The Next Web
Bloomberg

#biotechnology #drug-development #kevin-weil #openai

Ex-OpenAI Science Head Kevin Weil Launches Startup With $215 Million

Covered by 3 sources

More in Healthcare

Microsoft says its AI tool is better than doctors at diagnosing conditions

Can AI really predict cancer survival better than a doctor? I have my doubts | Devi Sridhar

What is Warhound, Palmer Luckey's war dog startup that just emerged from stealth?